Seroprevalence of hepatitis E virus among blood donors in Qatar (2013-2016)

Transfusion

Volumn 57, Issue 7, 2017, Pages 1801-1807

  Nasrallah, Gheyath K ^a,c   Al Absi, Enas S ^a   Ghandour, Rula ^d   Ali, Nadima H ^a   Taleb, Sara ^a   Hedaya, Laila ^a   Ali, Fatima ^a   Huwaidy, Mariam ^a   Husseini, Abdullatif ^b,d  

^a Department of Biomedical Sciences ^*  (Qatar)

^b QU Health   (Qatar)

^c QATAR UNIVERSITY   (Qatar)

^d BIRZEIT UNIVERSITY   (Palestine)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS RNA; HEPATITIS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; QATAR; REAL TIME POLYMERASE CHAIN REACTION; SEROPREVALENCE; YOUNG ADULT; BLOOD; ISOLATION AND PURIFICATION; SEROEPIDEMIOLOGY; STATISTICAL MODEL; TIME FACTOR;

BLOOD DONORS; HEPATITIS ANTIBODIES; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOGISTIC MODELS; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS;

EID: 85018338853     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14116     Document Type: Article

References (40)

1. Pérez-Gracia MT, Suay B, Mateos-Lindemann ML. Hepatitis E: an emerging disease. Infect Genet Evol 2014;22:40-59.
2. Yazbek S, Kreidieh K, Ramia S. Hepatitis E virus in the countries of the Middle East and North Africa region: an awareness of an infectious threat to blood safety. Infection 2016;44:11-22.
3. Mirazo S, Ramos N, Mainardi V, et al. Transmission, diagnosis, and management of hepatitis E: an update. Hepat Med 2014;6:45-59.
4. Parvez MK. Chronic hepatitis E infection: risks and controls. Intervirology 2013;56:213-6.
5. Stanaway JD, Flaxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 2016;388:1081-8.
6. Dreier J, Juhl D. Autochthonous hepatitis E virus infections: a new transfusion-associated risk? Transfus Med Hemother 2014;41:29-39.
7. Teshale EH, Hu DJ, Holmberg SD. The two faces of hepatitis E virus. Clin Infect Dis 2010;51:328-34.
8. Pelosi E, Clarke I. Hepatitis E: a complex and global disease. Emerg Health Threats J 2008;1:e8.
9. Wang S, Cheng X, Dai X, et al. Rabbit and human hepatitis E virus strains belong to a single serotype. Virus Res 2013;176:101-6.
10. Kamar N, Dalton HR, Abravanel F, et al. Hepatitis E virus infection. Clin Microbiol Rev 2014;27:116-38.
11. Aggarwal R. Hepatitis E: historical, contemporary and future perspectives. J Gastroenterol Hepatol 2011;26 Suppl 1:72-82.
12. Colson P, Romanet P, Moal V, et al. Autochthonous infections with hepatitis E virus genotype 4, France. Emerg Infect Dis 2012;18:1361-4.
13. Khuroo MS, Khuroo MS, Khuroo NS. Transmission of hepatitis E virus in developing countries. Viruses 2016;8. pii: E253.
14. Shidrawi RG, Skidmore SJ, Coleman JC, et al. Hepatitis E—an important cause of imported non-A, non-B hepatitis among migrant workers in Qatar. J Med Virol 1994;43:412-4.
15. Ibrahim AS, Alkhal A, Jacob J, et al. Hepatitis E in Qatar imported by expatriate workers from Nepal: epidemiological characteristics and clinical manifestations. J Med Virol 2009;81:1047-51.
16. Abro AH, Abdou AM, Saleh AA, et al. Hepatitis E: a common cause of acute viral hepatitis. J Pak Med Assoc 2009;59:92-4.
17. Kumar RM, Uduman S, Rana S, et al. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001;100:9-15.
18. Bhat SK, Sachdeva VN, Saleem HI. Profile of viral hepatitis patients in Dakhliya, Oman. Saudi Med J 2005;26:819-23.
19. Ayoola EA, Want MA, Gadour MO, et al. Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia. J Med Virol 2002;66:329-34.
20. Bawazir AA, Hart CA, Sallam TA, et al. Seroepidemiology of hepatitis A and hepatitis E viruses in Aden, Yemen. Trans R Soc Trop Med Hyg 2010;104:801-5.
21. Johargy AK, Mahomed MF, Khan MM, et al. Anti hepatitis E virus seropositivity in a group of male blood donors in Makkah, Saudi Arabia. J Pak Med Assoc 2013;63:185-9.
22. Abdelaal M, Zawawi TH, al Sobhi E, et al. Epidemiology of hepatitis E virus in male blood donors in Jeddah, Saudi Arabia. Ir J Med Sci 1998;167:94-6.
23. Ehteram H, Ramezani A, Eslamifar A, et al. Seroprevalence of hepatitis E virus infection among volunteer blood donors in central province of Iran in 2012. Iran J Microbiol 2013;5:172-6.
24. Ibrahim EH, Abdelwahab SF, Nady S, et al. Prevalence of anti-HEV IgM among blood donors in Egypt. Egypt J Immunol 2011;18:47-58.
25. Stramer SL, Moritz ED, Foster GA, et al. Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors. Transfusion 2016;56:481-8.
26. Kaufmann A, Kenfak-Foguena A, André C, et al. Hepatitis E virus seroprevalence among blood donors in southwest Switzerland. PLoS One 2011;6:e21150.
27. Lanini S, Garbuglia AR, Lapa D, et al. Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy. BMJ Open 2015;5:e007110.
28. Fischer C, Hofmann M, Danzer M, et al. Seroprevalence and incidence of hepatitis E in blood donors in Upper Austria. PLoS One 2015;10:e0119576.
29. Petrović T, Lupulović D, Jiménez de Oya N, et al. Prevalence of hepatitis E virus (HEV) antibodies in Serbian blood donors. J Infect Dev Cries 2014;8:1322-7.
30. Mansuy JM, Bendall R, Legrand-Abravanel F, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011;17:2309-12.
31. Khuroo MS. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res 2011;161:3-14.
32. Elduma AH, Osman WM. Dengue and hepatitis E virus infection in pregnant women in Eastern Sudan, a challenge for diagnosis in an endemic area. Pan Afr Med J 2014;19:391.
33. Centers for Disease Control and Prevention (CDC). Investigation of hepatitis E outbreak among refugees—Upper Nile, South Sudan, 2012-2013. MMWR Morb Mortal Wkly Rep 2013;62:581-6.
34. Rayis DA, Jumaa AM, Gasim GI, et al. An outbreak of hepatitis E and high maternal mortality at Port Sudan, Eastern Sudan. Pathog Glob Health 2013;107:66-8.
35. Aggarwal R. The global prevalence of hepatitis E virus infection and susceptibility: a systematic review. Geneva: World Health Organization; 2010.
36. Fix AD, Abdel-Hamid M, Purcell RH, et al. Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am J Trop Med Hyg 2000;62:519-23.
37. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012;379:2477-88.
38. Pawlotsky JM. Hepatitis E screening for blood donations: an urgent need? Lancet 2014;384:1729-30.
39. Vollmer T, Knabbe C, Dreier J. Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors. J Clin Microbiol 2014;52:2150-6.
40. Gupta E, Pandey P, Pandey S, et al. Role of hepatitis E virus antigen in confirming active viral replication in patients with acute viral hepatitis E infection. J Clin Virol 2013;58:374-7.